Turning Point Therapeutics, Inc.
TPTXDelisted Aug 17, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595893
Turning Point Therapeutics, Inc. was delisted on Aug 17, 2022; its insiders filed their last Form 4 on Aug 17, 2022; 209 institutions reported holding it in 13F filings for Q2 2022, worth $3.29B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2022
Institutional positions in Turning Point Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
TPTX is no longer listed, so this page shows Q2 2022. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 209
- +58 vs. Q1 2022
- Shares held
- 43.7M
- −2.06M (−4.5%) vs. Q1 2022
- Total value
- $3.29B
- +$2.06B (+167.2%) vs. Q1 2022
- New holders
- 96
- 44 more added
- Sold out
- 38
- 60 more reduced
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TPTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 209 | $3.29B |
| Q1 2022 | 154 | $1.23B |
| Q4 2021 | 172 | $2.15B |
| Q3 2021 | 191 | $2.98B |
| Q2 2021 | 190 | $3.59B |
| Q1 2021 | 202 | $4.21B |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Turning Point Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Alpine Associates Management Inc. | 1,028,400 | $77.4M | 2.91% | +1,028,400 | New |
| Farallon Capital Management, L.L.C. | 1,160,000 | $87.3M | 0.51% | +1,160,000 | New |
| FIL Ltd | 1,163,475 | $87.6M | 0.10% | +1,163,475 | New |
| State Street Corp | 1,650,689 | $124.2M | 0.01% | −1,469,237−47.1% | Reduced |
| Wellington Management Group LLP | 1,910,170 | $143.7M | 0.03% | −2,120,821−52.6% | Reduced |
| OrbiMed Advisors LLC | 2,012,250 | $151.4M | 2.94% | −6,700−0.3% | Reduced |
| Cormorant Asset Management, LP | 2,484,220 | $186.9M | 14.50% | −1,215,780−32.9% | Reduced |
| BlackRock Inc. | 3,791,801 | $285.3M | 0.01% | +99,587+2.7% | Added |
| Vanguard Group Inc | 4,157,552 | $312.9M | 0.01% | +244,424+6.2% | Added |
| Westfield Capital Management Co LP | 0 | $0 | 0.00% | −758,356−100.0% | Sold out |
| Massachusetts Financial Services Co | 0 | $0 | 0.00% | −365,205−100.0% | Sold out |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −351,350−100.0% | Sold out |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0 | $0 | 0.00% | −345,791−100.0% | Sold out |
| Eagle Asset Management Inc | 0 | $0 | 0.00% | −337,609−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −201,558−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −121,286−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −101,816−100.0% | Sold out |
| Brookfield Asset Management Inc. | 0 | $0 | 0.00% | −77,488−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −64,286−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −58,967−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −57,513−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −41,760−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −40,101−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −25,524−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −23,600−100.0% | Sold out |
| NinePointTwo Capital | 0 | $0 | 0.00% | −18,375−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −17,350−100.0% | Sold out |
| Duality Advisers, LP | 0 | $0 | 0.00% | −16,498−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −14,650−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −10,880−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −10,820−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −10,468−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −9,947−100.0% | Sold out |
| Cna Financial Corp | 0 | $0 | 0.00% | −9,403−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −9,060−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −8,834−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −3,893−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −2,800−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −92−100.0% | Sold out |
| TCWP LLC | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| ClariVest Asset Management LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Institutional & Family Asset Management, LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Disciplined Investments, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Cordant, Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| International Biotechnology Trust PLC | 0 | $0 | 0.00% | −14,093−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| IndexIQ Advisors LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |